Showing results (191-200 of 433) with videos related to
Sort By:
Pageof 44
Thrombosis Research|July 17, 2013
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancersAnubha Bharthuar, Alok A Khorana, Alan Hutson, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocoliticaDeyan Luo, Frank M Szaba, Lawrence W Kummer, et al.Blood|October 24, 2014
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorEvi X Stavrou, Chao Fang, Alona Merkulova, et al.Journal of Thrombosis and Haemostasis : JTH|October 20, 2019
Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulationAndrew D Meyer, Anjana R Rishmawi, Robin Kamucheka, et al.Blood Advances|December 30, 2022
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulationJun Wan, Pansakorn Tanratana, Mark Roest, et al.Blood Advances|December 8, 2022
Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in miceSteven P Grover, Vanthana Bharathi, Jens J Posma, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory DiseasesJens J Posma, Steven P Grover, Yohei Hisada, et al.Thrombosis Research|October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismDavid A Manly, Jianguo Wang, Sam L Glover, et al.Thrombosis Research|March 28, 2024
Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancerTomohiro Kawano, Cornelia Englisch, Yohei Hisada, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 21, 2010
Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injurySilvio Antoniak, Mauricio Rojas, Denise Spring, et al.Pageof 44